Clinical Trials Directory

Trials / Completed

CompletedNCT02084472

Accessible and Affordable Moisturizers for Atopic Eczema

Accessible and Affordable Moisturizers for Atopic Eczema: the 2am Atopic Eczema Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
120 (actual)
Sponsor
Red Cross War Memorial Childrens Hospital · Academic / Other
Sex
All
Age
6 Months – 12 Years
Healthy volunteers
Not accepted

Summary

Aqueous (EUA) cream, cetomacrogol (CMG) and emulsifying ointment (HEB) are in South Africa's essential drug list (EDL) but are not available to most rural patients. To assess whether accessible moisturizers can be used as alternatives in atopic eczema (AD), a randomized controlled trial of patients with mild-to-moderate AD, aged 1-12 years was conducted. Two separate sub-studies were conducted using a randomized controlled single (assessor) blind trial design. Study 1 compared UEA vs. liquid paraffin (unscented baby oil) for baths, all patients used HEB as moisturiser. In Study 2, 4 moisturisers were compared -HEB, CMG, petroleum jelly and petroleum jelly/Glycerine (2:1). Assessments (SCORAD, POEM, NESS and IQDOL) carried out at baseline, week 4, 8 and 12. Routine topical steroids and antihistamines were continued as prescribed.

Conditions

Interventions

TypeNameDescription
OTHERBaby oilpatient in study 1, arm B washed unscented liquid paraffin (baby oil) in place of aqueous cream
OTHERpetroleum jellypatients in this arm, use petroleum jelly (vaseline), replacing emulsifying ointment as a moisturiser
OTHERGlycerine:petroleum jelly 2:1patients in this arm use glycerine and petroleum jelly mixed at a ratio of 2:1 in place of cetomacrogol as a moisturiser

Timeline

Start date
2013-02-01
Primary completion
2013-05-01
Completion
2013-07-01
First posted
2014-03-12
Last updated
2014-03-12

Locations

1 site across 1 country: South Africa

Source: ClinicalTrials.gov record NCT02084472. Inclusion in this directory is not an endorsement.